UBS Group’s GMO US Value ETF GMOV Stock Holding History
Bought
Maintained
Sold
Other funds holding GMOV
CA
LCWP
FEG
SG
EP
UBS Group's GMOV Position: Q2 2026 in Review
UBS Group sold out of GMO US Value ETF (GMOV) in Q2 2026, closing a stake of 271 shares — an estimated $7.61K sold.
UBS Group first reported a position in GMOV in Q4 2024 and held it in 3 quarters. The position peaked at $15K in Q4 2024. 19 funds tracked by Wall St. Rank hold GMOV as of Q2 2026.
- UBS Group reported no remaining GMO US Value ETF position as of Q2 2026 after selling out during the quarter.
- UBS Group sold 271 GMO US Value ETF shares in Q2 2026, an estimated $7.61K.
- UBS Group first reported a position in GMO US Value ETF in Q4 2024 and held it in 3 quarters.
- UBS Group's GMO US Value ETF position peaked at $15K in Q4 2024.
- 19 funds tracked by Wall St. Rank held GMO US Value ETF as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.